Event Brief
South Africa plans lenacapavir rollout amid TB drug gaps
Filed: Jun 29, 2026 at 4:06 PM ET
Summary: South Africa’s HIV prevention injection lenacapavir rollout depends on managing TB medicines that can reduce its effectiveness.
WHO: Researchers and health officials in South Africa
WHAT: Developing strategies to keep people protected on lenacapavir while addressing interactions with commonly used TB medicines
WHEN: Jun 29, 2026 at 5:43 PM ET
WHERE: South Africa
WHY: Some commonly used TB medicines reduce lenacapavir’s effectiveness, creating evidence gaps that need strategies to maintain HIV prevention protection.
ℹ️ This event is analyzed using pattern arcs, velocity indicators, and source analysis in our MI Console.
Know more. Read less.
The BriefBrief follows the story, so you don't have to read every article. See what happened, how it changed, and where it came from, all in one place.
Same format. Every time.
See how stories unfold →